Adjuvia Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $8M

  • Investors
  • 3

Adjuvia Therapeutics General Information

Description

Developer of blood-brain barrier penetrant nanoparticle therapies designed to treat mitochondrial dysfunction. The company's technology utilizes a proprietary oral nanoparticle formulation and a patented harvesting method, enabling the delivery of small molecules across the blood-brain barrier to target rare and chronic degenerative diseases.

Contact Information

Website
www.adjuvia.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
+1 (424)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
+1 (424)

Adjuvia Therapeutics Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adjuvia Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 29-Jul-2026 $8M Completed Generating Revenue
1. Accelerator/Incubator 01-Aug-2024 Completed Generating Revenue
To view Adjuvia Therapeutics’s complete valuation and funding history, request access »

Adjuvia Therapeutics Patents

Adjuvia Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024369666-A1 Pharmaceutical composition and method of treating disease using a molecular complex assembled on astaxanthin core Pending 30-Oct-2023
EP-4801528-A1 Pharmaceutical composition and method of treating disease using a molecular complex assembled on astaxanthin core Pending 30-Oct-2023
WO-2025096604-A1 Pharmaceutical composition and method of treating disease using a molecular complex assembled on astaxanthin core Inactive 30-Oct-2023
US-20180094209-A1 Extraction of essential oils Inactive 15-Sep-2014
US-10227557-B2 Method and apparatus for producing astaxanthin Active 15-Sep-2014 C12N1/12
To view Adjuvia Therapeutics’s complete patent history, request access »

Adjuvia Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adjuvia Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
JLo Ventures Venture Capital Minority
Portfolia Venture Capital Minority
MBC BioLabs Accelerator/Incubator
To view Adjuvia Therapeutics’s complete investors history, request access »

Adjuvia Therapeutics FAQs

  • When was Adjuvia Therapeutics founded?

    Adjuvia Therapeutics was founded in 2023.

  • Where is Adjuvia Therapeutics headquartered?

    Adjuvia Therapeutics is headquartered in San Francisco, CA.

  • What is the size of Adjuvia Therapeutics?

    Adjuvia Therapeutics has 7 total employees.

  • What industry is Adjuvia Therapeutics in?

    Adjuvia Therapeutics’s primary industry is Drug Discovery.

  • Is Adjuvia Therapeutics a private or public company?

    Adjuvia Therapeutics is a Private company.

  • What is Adjuvia Therapeutics’s current revenue?

    The current revenue for Adjuvia Therapeutics is .

  • How much funding has Adjuvia Therapeutics raised over time?

    Adjuvia Therapeutics has raised $8M.

  • Who are Adjuvia Therapeutics’s investors?

    JLo Ventures, Portfolia, and MBC BioLabs have invested in Adjuvia Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process